logo
15:55 May 29

Medicamen Biotech Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
271.55
-13.05 (-4.59%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Medicamen Biotech Ltd. Financials

Medicamen Biotech Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
271.55
-13.05 (-4.59%)
15:55 May 29
Quality
image/svg+xml

62/100
High Financial Strength

Valuation
image/svg+xml

39/100
Mid Valuation

Technical

40/100
Technically Neutral

Strength

7

Weakness

4

Opportunity

1

Threats

0

3.49 %

ROE %

2.59 %

ROA %

8.01

EPS

203.17

BVPS

4.87 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales
115.45 140.87 179.31 162.55 197.77
Operating Expenses +
91.9 116.99 157.07 148.68 178.18
Raw Material
55.69 81.8 109.54 90.65 94.35
Increase Decrease in Cost
-3.34 -9.71 -16.94 -6.03 7.42
Other Manufacturing Expense
15.1 13.9 9.41 0 0
Employee Cost
14.5 20.44 30.07 31.87 34.69
Miscellaneous Expenses
9.95 10.56 34.67 32.19 41.72
Operating Profit
23.55 23.88 22.24 13.87 19.59
Other Income
1.72 2.46 2.33 6.24 3.11
Depreciation
5.77 6.37 7.09 7.07 7.22
Interest
1.4 2.92 4.4 3.16 3.5
Profit before tax and exceptio..
18.09 17.04 13.08 9.88 11.98
Exceptional Items
0 0 0 0 0
PBT
18.09 17.04 13.08 9.88 11.98
Provision for Taxation
3.2 2.32 3.58 3.32 2.19
Net Profit
14.9 14.73 9.49 6.56 9.8
NET Profit after MI
14.9 14.84 10.93 7.11 9.64
EPS
12.19 11.92 7.5 5.16 7.22
Operating Profit Margin (%)
20.4 16.95 12.4 8.53 9.91
Net Profit Margin (%)
12.91 10.53 6.1 4.37 4.87

Medicamen Biotech Ltd. Shareholding

All Data in Percentage (%)
Promoter - - - - -
FII - - - - -
Public - - - - -
MF - - - - -
Others
Shareholder Shares Holding %
Research 360 logo
Download Our App On: